CDKN2A and diabetic kidney disease: Clearance of p16-positive cells increases the activity of AMPK and decreases the activity of mTOR, leading to a normalization of the expression of mitochondrial metabolic genes, including the downregulation of Pdk1 (encoding pyruvate dehydrogenase kinases 1) in DKD kidneys.